(CIDRAP News) In releasing a new 5-year strategic plan yesterday, the federal agency tasked with developing new medical countermeasures (MCMs) for bioterrorist attacks and emerging diseases said many such products will be ready for regulatory review within the next 5 years.
(CIDRAP News) Coming a month after federal officials released a blueprint for overhauling the nation's civilian biodefense program, the US Department of Health and Human Services (HHS) today announced the award of eight contracts worth up to $100 million to modernize and speed the development of countermeasures against natural and man-made disease threats.
(CIDRAP News) The US Department of Health and Human Services (HHS) yesterday released a draft of its national vaccine strategy, which, once finalized, will serve as the federal government's game plan for guiding its policy decisions on infectious disease vaccine.
The 85-page report, dated Nov 26, is intended to update the nation's vaccine plan, which was mandated by Congress and first released in 1994, according to the report.
(CIDRAP News) The United States was on track to provide 100 million doses of influenza vaccine this year when half of its supply was withdrawn in early October because of contamination concerns over vaccine from Chiron Corp. Suddenly about 48 million doses shy of the expected supply, US officials scrambled to define priorities.